Roivant Sciences(ROIV.US)

Last Updated 19:00:00 ET
longbridge loading

Roivant Sciences Ltd. Stock 12‑Month Price Target Raised to $36.23, Implies 28% Upside

TradingView·
US
ROIV
-1.19%
US
IXJ
+0.79%
US
FBT
+0.54%
TradingView·
US
ROIV
-1.19%
US
IXJ
+0.79%
US
FBT
+0.54%

Pre-Market Earnings Report for May 20, 2026 : ADI, TJX, LOW, TGT, ROIV, HAS, GDS, VFC, BZ, IMVT, ZIM, ARCO

nasdaq·
US
HAS
+3.69%
US
TGT
+3.11%
US
ROIV
-1.19%
nasdaq·
US
HAS
+3.69%
US
TGT
+3.11%
US
ROIV
-1.19%

Top Biotech Insider Makes Bold Multi-Million Dollar Stock Move

Tip Ranks·
US
ROIV
-1.19%
US
IBB
+0.10%
US
SBIO
-1.24%
Tip Ranks·
US
ROIV
-1.19%
US
IBB
+0.10%
US
SBIO
-1.24%

Roivant Sciences CEO Sold Shares Worth Over $8.4M

TradingView·
US
ROIV
-1.19%
TradingView·
US
ROIV
-1.19%

Roivant Sciences (ROIV) Gets a Buy from J.P. Morgan

Tip Ranks·
US
ROIV
-1.19%
US
IBB
+0.10%
US
XBI
-0.69%
Tip Ranks·
US
ROIV
-1.19%
US
IBB
+0.10%
US
XBI
-0.69%

A Look At Roivant Sciences (ROIV) Valuation As Analyst Upgrades And Brepocitinib Progress Lift Sentiment

Simplywall·
US
ROIV
-1.19%
US
BBH
+0.68%
US
XBI
-0.69%
Simplywall·
US
ROIV
-1.19%
US
BBH
+0.68%
US
XBI
-0.69%

Is Brepocitinib’s LPP Trial And Mixed Batoclimab Data Altering The Investment Case For Roivant Sciences (ROIV)?

Simplywall·
US
PBE
+0.11%
US
XLV
+1.10%
US
FBT
+0.54%
Simplywall·
US
PBE
+0.11%
US
XLV
+1.10%
US
FBT
+0.54%

Bioharvest Sciences Earnings Call Highlights Growth Momentum

Tip Ranks·
US
XHE
+0.66%
US
HBIO
+0.20%
US
ARKG
+0.04%
Tip Ranks·
US
XHE
+0.66%
US
HBIO
+0.20%
US
ARKG
+0.04%

ROIS establishes itself as Global CDMO with US Expansion

biopharmadive·
US
IBBQ
+0.07%
US
IBB
+0.10%
US
FBT
+0.54%
biopharmadive·
US
IBBQ
+0.07%
US
IBB
+0.10%
US
FBT
+0.54%
© 2026 Longbridge｜Disclaimer